The ‘most advanced marijuana investment conference in history’ marks a significant shift in the industry
The organizers of a marijuana investment conference to he held in Toronto on June 22, 2015 are inviting domestic and foreign accredited investors alike to attend the most advanced marijuana investment conference in history, marking a significant shift in the marijuana industry.
A year ago the stock market appraised the marijuana industry, giddily taking note of Charlotte’s web and other wonderful pot strains. The industry and its unique product spurred conferences attracted the curious. It was about buzz.
But this new conference by Jacob Securities shows a new trend in the marijuana industry. A significant cultural obstacle seems to have been overcome. It is no longer about just “growing pot”. The conspirational giggling and winking are gone. Investors are now are looking at metrics and assessing growth potential. There is a palpable seriousness one would recognize in a more mature industry line the pharmaceutical sector.
The conference organizers have room for 220 participants who should expect to be exposed to the substantive knowledge of experts in the medical marijuana industry. However, this is not a place to merely learn about how to grow pot. Investors now know that growing cannabis is easy but that producing medicine is a different thing altogether. Therefore those who are new to the industry should expect a steep learning curve.
Canada is the most sophisticated jurisdiction anywhere in the world for safe investing in marijuana. It is not a mere coincidence that the conference should be held in Canada. And no, it’s not because heavy-lidded cannabis enthusiasts have devoutly replaced the Maple Leaf with a multifolioled cannabis leaf.
Since the implementation of the MMPR regulations, licensed producers have spent the past year fine-tuning the process of growing, packaging, monitoring, controlling and reporting the quality of their produce in a complex regulatory environment. Canada now produces the highest quality medical marijuana in the world. Among its many qualities, Canadian marijuana boasts an absence of pesticides, reports both its THC and CBD contents and flaunts its tightly monitored microbiological loads; Canadian licensed producers are not producing pot anymore.
Get our daily investorintel update
Investors will also have the opportunity to assess newly released financial metrics from the first year of MMPR operations, which will then offer them the opportunity to evaluate and compare the performance of various producers.
Either through Darwinian luck or adaptive planning, real winners are emerging from the over 600 applicants for cannabis production to Health Canada. Investors should be delighted since they now have the pick of the crop. Corporate governance, good manufacturing practices, standard operating procedures and quality control are now common topics of discussion and represent serious evaluation criteria.
The Canadian cannabis experiment is working for the licensed producers who were lucky enough to secure the first licences.
Serious cannabis investors are well advised to attend this conference: the industry is no longer about growing pot, but is instead concerned with encouraging profitable investment in the most tightly regulated medicinal marijuana industry in the world.
Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published ... <Read more about Dr. Luc Duchesne>